State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
All content for Unblinded: A Clinical Trial Podcast is the property of Veeva Systems and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
Putting Patient Data at the Heart of Your Strategy
Unblinded: A Clinical Trial Podcast
40 minutes
1 year ago
Putting Patient Data at the Heart of Your Strategy
<p>In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect novel insights from large volumes of data. But has this influx of data and tech caused us to move farther away from the patients we serve?</p>
<p>Together Terttu, Leonie, and Richard outline the major opportunities for life sciences organizations to put patients back at the heart of clinical strategy. </p>
<p>Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.</p>
<p><br></p>
Unblinded: A Clinical Trial Podcast
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
